Caricamento...
Identification of favorable subgroups for alternative anti-androgen therapy in castration-resistant prostate cancer
Although alternative anti-androgen therapy (switching to secondary anti-androgens) is no longer recommended in the clinical guidelines of prostate cancer in light of the new hormonal and cytotoxic agents available, this therapy has proven beneficial for some patients with castration-resistant prosta...
Salvato in:
| Pubblicato in: | Mol Clin Oncol |
|---|---|
| Autori principali: | , , , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
D.A. Spandidos
2019
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6787950/ https://ncbi.nlm.nih.gov/pubmed/31620284 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2019.1915 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|